Vivos Therapeutics, Inc. (VVOS) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $26.70M | +264.3% |
| 2024 | $7.33M | -29.0% |
| 2023 | $10.32M | +15.7% |
| 2022 | $8.92M | +9.4% |
| 2021 | $8.15M | -3.1% |
| 2020 | $8.41M | -8.4% |
| 2019 | $9.18M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $26.70M | +264.3% |
| 2024 | $7.33M | -29.0% |
| 2023 | $10.32M | +15.7% |
| 2022 | $8.92M | +9.4% |
| 2021 | $8.15M | -3.1% |
| 2020 | $8.41M | -8.4% |
| 2019 | $9.18M | — |